Form4insider filings, from the source

SEC Form 4 · accession 0001106578-26-000119

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Aug 12, 2026
Accepted (ET)
Aug 13, 2026 · 5:09 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Aug 12, 2026M9,500$135.42A333,943Iby Trust
Common StockF3,F2Aug 12, 2026S40$507.076D333,903Iby Trust
Common StockF4,F2Aug 12, 2026S440$508.8598D333,463Iby Trust
Common StockF5,F2Aug 12, 2026S280$509.6114D333,183Iby Trust
Common StockF6,F2Aug 12, 2026S1,152$511.1178D332,031Iby Trust
Common StockF7,F2Aug 12, 2026S542$511.7471D331,489Iby Trust
Common StockF8,F2Aug 12, 2026S1,206$513.0168D330,283Iby Trust
Common StockF9,F2Aug 12, 2026S558$514.1839D329,725Iby Trust
Common StockF10,F2Aug 12, 2026S893$514.8746D328,832Iby Trust
Common StockF11,F2Aug 12, 2026S940$516.1606D327,892Iby Trust
Common StockF12,F2Aug 12, 2026S1,249$517.2146D326,643Iby Trust
Common StockF13,F2Aug 12, 2026S320$518.1566D326,323Iby Trust
Common StockF14,F2Aug 12, 2026S1,160$519.4888D325,163Iby Trust
Common StockF15,F2Aug 12, 2026S679$520.3779D324,484Iby Trust
Common StockF16,F2Aug 12, 2026S41$520.9598D324,443Iby Trust
Common Stockholding———40,513D
Common Stockholding———166Iby Spouse
Common StockF17holding———249,108Iby Trust
Common StockF18holding———45,596Iby Trust
Common StockF19holding———8,902Iby Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF20$135.42Aug 12, 2026M9,500DMar 15, 2023Mar 15, 2027Common Stock9,500151,410I

Explanation of responses